This draft guidance describes considerations regarding a comparative clinical study or studies with efficacy endpoints (a comparative efficacy study or CES) intended to support a demonstration that a proposed therapeutic protein product is biosimilar to a reference product.
Similar Posts
Go Raw, LLC. Issues Voluntary Recall of a Single Lot of Quest Cat Food Chicken Recipe Freeze Dried Nuggets Due to Low Levels of Thiamine (Vitamin B1)
Go Raw LLC is voluntarily recalling a single lot of Quest Cat Food Chicken Recipe Freeze Dried Nuggets, 10oz bag, lot code #C25288, Best Buy Date 10/15/2027, because it may contain low levels of thiamine (Vitamin B1).State Importation Program Enhancements
FDA is committed to continuing to work with states and Indian tribes that seek to develop an importation proposal under section 804 of the Federal Food, Drug and Cosmetic Act.Raw Bistro Pet Fare Voluntarily Recalls Frozen Beef Entrée Because of Possible Salmonella Health Risk
October 9, 2025 – Raw Bistro Pet Fare, Cannon Falls, MN is voluntarily recalling two product sizes of its frozen beef dog food because they may be contaminated with Salmonella.CDER Small Business and Industry Assistance (SBIA) Learn
SBIA Learn offers a variety of multimedia resources to provide information that is comprehensive, interactive, and easily accessible to small pharmaceutical business and industry.MEGA 7G 700000 contains hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use MEGA 7G 700000, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.Abbott Initiates Medical Device Correction for Certain FreeStyle Libre® 3 and FreeStyle Libre 3 Plus Sensors in the U.S.
ABBOTT PARK, Ill., Nov. 24, 2025 — Abbott has initiated a medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors in the United States after internal testing determined that some sensors may provide incorrect low glucose readings.